XML 55 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Segments (Tables)
12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Operations and Assets for Operating Segments and Geographic Information Information regarding our operations and assets for our operating segments and the unallocated corporate operations as well as geographic information are as follows:
 For the years ended December 31,
(In thousands)202220212020
Revenue from services:
Pharmaceutical$— $— $— 
Diagnostics755,630 1,607,106 1,262,242 
Corporate— — — 
$755,630 $1,607,106 $1,262,242 
Revenue from products:
Pharmaceutical$142,845 $141,770 $119,952 
Diagnostics— — — 
Corporate— — — 
$142,845 $141,770 $119,952 
Revenue from transfer of intellectual property and other:
Pharmaceutical$105,721 $25,842 $36,979 
Diagnostics— — 16,240 
Corporate— — — 
$105,721 $25,842 $53,219 
Operating income (loss):
Pharmaceutical$(12,961)$(19,051)$(43,519)
Diagnostics(173,652)98,067 138,922 
Corporate(39,640)(60,266)(37,689)
$(226,253)$18,750 $57,714 
Depreciation and amortization:
Pharmaceutical$68,618 $26,427 $29,001 
Diagnostics40,037 52,289 56,361 
Corporate— — — 
$108,655 $78,716 $85,362 
Loss from investment in investees:
Pharmaceutical$(383)$(629)$(480)
Diagnostics— — — 
Corporate— — — 
$(383)$(629)$(480)
Revenues:
U.S.$783,207 $1,640,354 $1,317,766 
Ireland117,214 32,809 43,920 
Chile62,044 63,798 44,153 
Spain22,477 22,682 16,932 
Israel3,845 3,563 4,251 
Mexico14,546 11,005 7,865 
Other863 507 526 
$1,004,196 $1,774,718 $1,435,413 
(In thousands)December 31,
2022
December 31,
2021
Assets:
Pharmaceutical$1,322,531 $1,114,460 
Diagnostics690,504 1,238,583 
Corporate154,224 46,672 
$2,167,259 $2,399,715 
Goodwill:
Pharmaceutical$312,826 $237,576 
Diagnostics283,025 283,025 
$595,851 $520,601 
Property, Plant and Equipment, Net by Jurisdiction
The following table reconciles our Property, plant and equipment, net between U.S. and foreign jurisdictions: 
(In thousands)December 31, 2022December 31, 2021
PP&E:
U.S.$52,795 $50,559 
Foreign30,084 29,168 
Total$82,879 $79,727